Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Grants
$2.2M
4 grants · CORDIS
Backers
1
NRW.BANK
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 1 Won a grant $174k · CORDIS Jul 1 Won a grant $1.7M · CORDIS Sep 1, 2024 Won a grant $161k · CORDIS Apr 1, 2024 Won a grant $138k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Grant Aug 2026 $174k — CORDIS
Grant Jul 2026 $1.7M — CORDIS
Grant Sep 2024 $161k — CORDIS
Grant Apr 2024 $138k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity 4TEEN4 Pharmaceuticals GmbH its site
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Cryotherapeutics11-50 employees
Implant-free cryotherapy. Solutions to stabilize vulnerable plaques and reduce heart attack risk.
Learn about BLINCYTO® (blinatumomab), a treatment for adults and children with CD-19 positive B-cell precursor acute lymphoblastic leukemia…
OK2StandUPVenture round $60k · 4 yr ago • Founded 2021
Mitigate Falls. Prevent Injuries. Improve Lives. Introducing the first artificial intelligence fall mitigation solution for caregivers.
aiomicsFounded 2025 • 201-500 employees
Medical letter drafts, referrals and admissions, payer enquiries and digital patient questionnaires. aiomics supports rehabilitation and…
Explore the latest clinical evidence, case reviews and best practices for Protected PCI, AMI cardiogenic shock, right heart failure…
The next great hospitalwon't have a building.. We make ongoing treatment automatic.Starting with GLP-1.

Overview

Cardiogenic Shock: the primary circulatory shock in ICUs with a mortality rate over 70%. Triggered by acute myocardial injuries like heart attacks, it leads to severe left-ventricular dysfunction. Despite advancements in care and treatment for up to 200,000 affected U.S.

Financials

Total raised
$2.2M
Latest round
Grant
Funding rounds
4
Funding rounds
Round Announced Amount
Grant 2026 $174k Details
Grant 2026 $1.7M Details
Grant 2024 $161k Details
Grant 2024 $138k Details